Neuroblastoma is a highly malignant epithelial neurocyte tissue tumor, which is relatively aggressive. Often in the early stages of the disease, the tumor tissue adheres to surrounding brain tissue, nerves, and blood vessels, making it impossible to completely remove it surgically. The residual tumor cells quickly recur over time. As a result, most neuroblastoma patients have a poor prognosis and short survival time, even with effective surgical treatment, including postoperative radiotherapy and chemotherapy. Therefore, it is recommended that those diagnosed with neuroblastoma undergo early further examinations and treatments.